The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Do not initiate in rapidly or acutely deteriorating COPD or asthma. Not for use with other long-acting β 2-agonists. Do not exceed recommended dose. Prescribe a short-acting, inhaled β 2-agonist ...

By providing quick relief to individuals experiencing asthma symptoms at schools, stock inhalers prevent emergency room ...

Breo Ellipta, a dual-therapy inhaler combining an ICS and LABA, was similarly found to provide comparable or incremental net health benefits when compared to generic ICS/LABA inhalers. ICER's ...

The sensor attaches to the top of the Ellipta inhaler ... of its asthma and COPD medication Advair are declining, and payers are demanding more from its next generation treatments Breo and Anoro ...